このページを印刷する このページを印刷する
IBSA FARMACEUTICI ITALIA SRL
ブース番号 IP-04 パビリオン イタリアパビリオン
住所 Via Martiri di Cefalonia 2, LODI 26900
TEL 39-0371-6171
FAX 39-0371-617244
URL http://www.ibsa.it
Email massimo.quattrini@ibsa.it
出展品目 TIROSINT®: liquid levothyroxine formulation for the treatment of hypothyroidism, available in soft gel and mono-dose with a wide range of concentrations. FDA approved.新製品
SILANDYL®: new orodispersible film formulation of Sildenafil, available in dosages of 25, 50, 75 and 100 mg and in different and convenient pack-sizes of 2, 4 and 8 films.新製品
SINOVIAL® HL: high concentration of HA 32mg/ml in pre-filled syringes for intra-articular injection for viscosupplementation. New hybrid cooperative complexes of HA with unique rheological characteristics and viscoelastic properties. IBSA's exclusive patented innovation. Medical device with CE marking.新製品
IALURIL® Prefill: Sodium Hyaluronate and Chondroitin Sulfate sterile solution for intravesical instillation. Indicated to treat chronic inflammatory diseases of the bladder originated from damage of the GAG layer. Available in 50mL pre-filled luer lock syringe. Medical device with CE marking.
PROLUTEX®: innovative aqueous solution of progesterone for subcutaneous administration. Indicated for luteal phase support in ART programs, original excipient-free formulation, allowing self-administered subcutaneous injections. Available in vials containing 25mg of progesterone, HPBCD and water for injection. 新製品
MERIOFERT®: Highly Purified hMG
FOSTIMON®: Highly Purified hFSH
CHORIOMON®: Highly Purified hCG
AKIS®: diclofenac sodium (25mg, 50mg and 75mg) formulated in 1 mL of aqueous solution either in a ready-to-use prefilled syringe or ampoule. Suitable for intramuscular (IM), subcutaneous (SC) injection and even bolus intravenous (IV) injection.
FLECTOR® TISSUGEL: medicated plaster comprised of a self adhering poultice containing 1.3% diclofenac epolamine. Effective anti­inflammatory and analgesic action directly to the site of inflammation, with a slow and continuous release of diclofenac covering over 24 hours just applying one to two patches a day. FDA approved.
FLECTORMED®: medicated plaster containing DHEP 180 mg as active principle and heparin sodium 5,600 IU as excipient in a selfadhering poultice. Enhanced release of the active principle, efficacy in minor painful conditions, especially sport traumas even in the presence of oedema. Once a day application. FDA approved.
IALUSET®: Hyaluronic Acid for topical use. Indicated for the treatment of non-infected wounds and burns. Available in cream and gauze pads. Medical device with CE marking.
IALUSET® PLUS: Hyaluronic Acid + Silver Sulfadiazine for topical use. Indicated for the treatment of wounds, ulcers, burns, even in cases where injuries are infected. Available in cream and gauze pads. Medical device with CE marking.
BETESIL®: Betamethasone 17-valerate 2.250mg medicated plaster for topical application in the treatment of severe inflammatory skin disorders unresponsive to less potent corticosteroids such as eczemas, psoriasis, lichenifications, lichen planus, granuloma annulare, pustolosis palmaris and plantaris, mycosis fungoides and other recal­citrant dermatoses.
ロゴ・写真
見どころ イブサは1945年に創設された非公開製薬企業で、5大陸・80ヶ国超で事業展開しています。
イブサは、先端製造技術によって特定の治療分野のグローバル市場において主導的地位を築いており、現在では欧州、中イブサは1945年に創設された非公開製薬企業で、5大陸・80ヶ国超で事業展開しています。
イブサは、先端製造技術によって特定の治療分野のグローバル市場において主導的地位を築いており、現在では欧州、中国、米国に11の支社と、関連企業、駐在員事務所を有しています。本社、支社、そしてスイス、イタリア、中国における11箇所の製造拠点で業務に従事しする当グループの従業員は1600名に上ります。